The Coleman Institute Blog
29
Feb 16
Probuphine – A New Buprenorphine Implant
Probuphine® was first approved by the Food and Drug Administration (FDA) in 2016 and prior to approval had several studies conducted that aided in approving its treatment for opioid use disorder (OUD). The test made significant progress in showing participants who continued their previous scheduled regimen for opioid detox with the addition of a probuphine implant. After thorough observation from the participant study those that implemented probuphine to their treatments showed significant positive change in energy, sleep, and overall quality of life.
What makes this treatment unique, is that it provides a continual, low-level dose for up to six months for those who are already stable on low-to-moderate doses of other forms of buprenorphine. Additionally, it is the only type of treatment that is in the form of an implant, whereas other opioid medications are typically found in forms of pills or films. This alone provides patients with a convenient means of not needing to resort to taking a pill daily.
Currently, over 10.1 million Americans misuse opioids at least once over a 12-month period. With treatment options like Probuphine, it revolutionizes the method of opioid treatment and controls cravings or withdrawal symptoms to result in balance, self-control, and management.
(more…)
4
Jan 16
6 Ways to Keep your Resolution for Sobriety
For those struggling with an addiction to alcohol or another substance, the end of the year can be a challenging time. Thanksgiving, Christmas, and New Year’s can bring up old temptations and triggers that can make your goal for sobriety seem out of reach. But now that the overindulgent holidays are past us, we can focus on the possibilities of the New Year that lies ahead.
(more…)
